IRWD icon

Ironwood Pharmaceuticals

226 hedge funds and large institutions have $1.12B invested in Ironwood Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 79 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

26% less capital invested

Capital invested by funds: $1.5B → $1.12B (-$383M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

60% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 52

Holders
226
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73.6M
Puts
$186K
Net Calls
Net Calls Change

Top Buyers

1 +$17M
2 +$15.4M
3 +$14.4M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
+$12M
5
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M

Top Sellers

1 -$33.1M
2 -$9.79M
3 -$9.06M
4
UBS Group
UBS Group
Switzerland
-$8.4M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.83M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$525K
102
$523K
103
$503K
104
$502K
105
$491K
106
$474K
107
$470K
108
$459K
109
$445K
110
$440K
111
$433K
112
$432K
113
$415K
114
$407K
115
$400K
116
$394K
117
$392K
118
$392K
119
$391K
120
$376K
121
$364K
122
$359K
123
$356K
124
$329K
125
$328K